Evidence map›Paper›PMID 32825564›Full record

ReviewNutrients2020

Antiviral Properties of Flavonoids and Delivery Strategies.

Paolino Ninfali, Antonella Antonelli, Mauro Magnani, Emanuele Salvatore Scarpa

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 1 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 1 synthesis or guideline pooled it, 191 citations in OpenAlex.

  1. The Antiviral Potential ofMolecules (Basel, Switzerland) · 2024
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Pharmaceutics · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Paolino NinfaliDepartment of Biomolecular Sciences, Section of Biochemistry and Biotechnologies, University of Urbino Carlo Bo, 61029 Urbino, Italy.ORCID 0000-0003-4471-725X
Antonella AntonelliDepartment of Biomolecular Sciences, Section of Biochemistry and Biotechnologies, University of Urbino Carlo Bo, 61029 Urbino, Italy.
Mauro MagnaniDepartment of Biomolecular Sciences, Section of Biochemistry and Biotechnologies, University of Urbino Carlo Bo, 61029 Urbino, Italy.ORCID 0000-0001-6456-6626
Emanuele Salvatore ScarpaDepartment of Biomolecular Sciences, Section of Biochemistry and Biotechnologies, University of Urbino Carlo Bo, 61029 Urbino, Italy.
University of Urbino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review summarizes the latest advancements in phytochemicals as functional antiviral agents. We focused on flavonoids, like apigenin, vitexin, quercetin, rutin and naringenin, which have shown a wide range of biological effects including antiviral activities. The molecular mechanisms of their antiviral effects mainly consist in the inhibition of viral neuraminidase, proteases and DNA/RNA polymerases, as well as in the modification of various viral proteins. Mixtures of different flavonoids or combination of flavonoids with antiviral synthetic drugs provide an enhancement of their antiviral effects. Recent strategies in drug delivery significantly contribute to overcoming the low bioavailability of flavonoids. Frequent viral infections worldwide have led to the need for new effective antiviral agents, which can be identified among the various phytochemicals. In this light, screening the antiviral activities of a cocktail of flavonoids would be advantageous in order to prevent viral infections and improve current antiviral therapies.

Indexed as

Antiviral AgentsDrug Delivery SystemsApigeninBiological AvailabilityDrug CombinationsDrug Evaluation, PreclinicalDrug SynergismFlavanonesFlavonoidsHumansNeuraminidaseQuercetinRutinViral Protease InhibitorsViral ProteinsVirus DiseasesAntiviral AgentsApigeninDrug CombinationsFlavanonesFlavonoidsnaringeninNeuraminidaseQuercetinRutinViral Protease InhibitorsViral Proteinsvitexinantiviral propertiesflavonoidsphytochemical delivery strategiesviral enzymes

Identifiers

PMID32825564
PMCPMC7551920
OpenAlexW3074516067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.